Vijai Mohan

Vijai Mohan has a long history of work experience in the healthcare industry. Vijai began their career in 1999 as an Investment Banking Analyst at Credit Suisse. In 2000, they joined Prudential Financial as an Associate Analyst in the biotechnology sector. In 2001, they moved to Onyx Pharmaceuticals, Inc., an Amgen subsidiary, as a Manager of Corporate Finance. Vijai then joined Origin Capital Management as a Director of Research, Co-Portfolio Manager, and Partner. In 2008, they founded Hyphen Fund Management and served as a Portfolio Manager. In 2018, they joined Arcline Investment Management as a Partner in the Life Sciences sector. In 2017, they Co-Founded CellChorus and served as a Board Director. Vijai also founded Secure Transfusion Solutions in 2017 and serves as the CEO. In 2021, they joined the Advisory Board of the Vagelos Life Sciences and Management Program at the University of Pennsylvania.

Vijai Mohan attended Copley High School from 1990 to 1994. Vijai then went on to the University of Pennsylvania, where they earned a Bachelor's degree in Molecular Biology and Economics in 1998. In 1999, they completed their Master's degree in Biotechnology at the University of Pennsylvania. Vijai also holds a Chartered Financial Analyst certification from the CFA Institute.